Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-03 Sale |
2025-03-04 8:56 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer |
124,893 | $7.9622 | $994,425 | 806,881 (Direct) |
View |
| 2024-03-06 Sale |
2024-03-07 4:43 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
40,665 | $5.51 | $224,064 | 584,072 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:04 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Internal Operations |
10,000 | $4.66 | $46,600 | 27,927 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:12 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
3,052 | $12.01 | $36,655 | 298,367 (Direct) |
View |
| 2021-05-11 Purchase |
2021-05-12 4:34 pm |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
9,900 | $10.07 | $99,739 | 9,900 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 8:56 pm |
N/A 2035-02-28 |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer |
344,764 | $0 | 806,881 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:31 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
216,666 | $0 | 624,737 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:29 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy |
271,134 | $0 | 403,141 (Direct) |
View |
| 2022-03-02 Option Award |
2022-03-04 4:12 pm |
N/A N/A |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
290,643 | $0 | 298,367 (Direct) |
View |
Ownership |
2021-01-04 5:48 pm |
N/A 2029-08-19 |
Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations |
0 | $0 | 613,452 (Direct) |
View |